Inactive Instrument
Argos Therapeutics Inc Stock Nasdaq
Stocks
US0402211033
Pharmaceuticals
OTC Markets Traded| Market Cap | 318K 273K 257K 234K 440K 30.22M 443K 3.04M 1.18M 15.32M 1.19M 1.17M 50.74M | P/E 2016 |
-2.96x | P/E 2017 | -0.22x |
|---|---|---|---|---|---|
| Enterprise Value | 4.58M 3.95M 3.71M 3.38M 6.36M 436M 6.4M 43.92M 17.09M 221M 17.22M 16.84M 732M | EV / Sales 2016 |
200x | EV / Sales 2017 | 9.19x |
| Free-Float |
88.73% | Yield 2016 * |
-
| Yield 2017 | - |
| 1 day | +0.46% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.46% | +1,231.29% | - | - | 567K | |
| +0.59% | -3.80% | +37.92% | -3.56% | 79.3B | |
| -0.44% | +1.94% | -19.41% | -36.90% | 59.21B | |
| +3.38% | +2.31% | +487.41% | +25.67% | 55.09B | |
| +2.15% | -2.13% | -1.37% | +30.77% | 49.86B | |
| -0.55% | -2.14% | +8.08% | +160.02% | 47.9B | |
| -0.00% | +0.10% | +56.36% | -18.34% | 32.28B | |
| -0.49% | -3.42% | +43.75% | +91.54% | 25.21B | |
| -3.44% | +1.37% | +7.18% | +188.73% | 23.87B | |
| -3.52% | -0.49% | +58.94% | +112.57% | 16.89B | |
| Average | -0.19% | -1.05% | +75.43% | +61.17% | 43.29B | |
| Weighted average by Cap. | +0.34% | -1.88% | +85.00% | +41.75% |
| 2016 | 2017 | |
|---|---|---|
| Net sales | 945K 814K 764K 698K 1.31M 89.96M 1.32M 9.06M 3.52M 45.62M 3.55M 3.47M 151M | 1.9M 1.64M 1.54M 1.4M 2.63M 181M 2.65M 18.2M 7.08M 91.64M 7.13M 6.98M 303M |
| Net income | -53.03M -45.66M -42.87M -39.13M -73.52M -5.05B -74.04M -508M -198M -2.56B -199M -195M -8.47B | -40.58M -34.94M -32.8M -29.95M -56.26M -3.86B -56.66M -389M -151M -1.96B -152M -149M -6.48B |
| Net Debt | -13.11M -11.29M -10.6M -9.67M -18.17M -1.25B -18.3M -126M -48.86M -632M -49.22M -48.15M -2.09B | 4.27M 3.67M 3.45M 3.15M 5.92M 406M 5.96M 40.88M 15.91M 206M 16.02M 15.67M 682M |
Employees
-
Sector
Pharmaceuticals
